Mind-body medicine: Stress, stress management and health promotion;Mind-body-medizin: Stress, stressmanagement und gesundheitsförderung

KIM - Komplementare und Integrative Medizin, Artztezeitschrift fur Naturheilverfahren

Volumn 49, Issue 1, 2008, Pages 35-39

  Esch, Tobias ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b Robotics Research Lab   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; HEALTH PROMOTION; MEDITATION; PHYSIOTHERAPY; REVIEW; STRESS; STRESS MANAGEMENT; TAI CHI;

EID: 39149111207     PISSN: 18638678     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kim.2007.10.002     Document Type: Article

References (41)

1. Stefano GB, Benson H, Fricchione GL et al. The Stress Response: Always Good and When It Is Bad. Warsaw-New York: Medical Science International; 2005.
2. Esch T. Gesund im Stress: Der Wandel des Stresskonzeptes und seine Bedeutung für Prävention, Gesundheit und Lebensstil. Gesundheitswesen 2002; 64: 73-81.
3. Komaroff AL (Hrsg.). Mind-Body Medicine: A Special Health Report. Boston: Harvard Health Publications; 2001.
4. National Center for Complementary and Alternative Medicine.http://nc-cam. nih.gov/health/backgrounds/mindbody.htm (Zugriff 20.7.07).
5. Dobos G, Altner N, Lange S et al. Mind-Body-Medicine als Bestandteil der Integrativen Medizin. Bundesgesundheitsblatt 2006; 49: 723-728.
6. Esch T. Stress, Anpassung und Selbstorganisation: Gleichgewichtsprozesse sichern Gesundheit und Überleben. Forsch Komplementarmed 2003; 10: 330-341.
7. Esch T, Stefano GB, Fricchione GL et al. An overview of stress and its impact in immunological diseases. Mod Asp Immunobiol 2002; 2: 187-192.
8. Esch T, Stefano GB, Fricchione GL et al. Stress in cardiovascular diseases. Med Sci Monit 2002; 8: RA93-RA101.
9. Esch T, Stefano GB, Fricchione GL et al. The role of stress in neurodegenerative diseases and mental disorders. Neuroendocrinol Lett 2002; 23: 199-208.
10. Selye H. The Physiology and Pathology of Exposure to Stress. Montreal: Acta Inc. Medical Publishers; 1950.
11. McEwen BS. Protective and damaging effects of stress mediators. New Engl J Med 1998; 338: 171-179.
12. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 1992; 267: 1244-1252.
13. Cannon W. The emergency function of the adrenal medulla in pain and the major emotions. Am J Physiol 1914; 33: 356-372.
14. McCarty R, Gold P. Catecholamines, stress and disease: A psychobiological perspective. Psychosom Med 1996; 58: 590-597.
15. Kuper H, Singh-Manoux A, Siegrist J et al. When reciprocity fails: Effort-reward imbalance in relation to coronary heart disease and health functioning within the Whitehall II study. Occup Environ Med 2002; 59: 777-784.
16. Siegrist J. Verletzte soziale Reziprozität macht krank: Ein medizinsoziologisches Forschungsmodell. Forsch Komplementarmed 2002; 9: 31-36.
17. Kivimäki M, Leino-Arjas P, Luukonen R et al. Work stress and risk of cardiovascular mortality: Prospective cohort study of industrial employees. BMJ 2002; 325: 857.
18. Esch T. Die Bedeutung von Stress für das Herz-Kreislauf-System: Stress-assoziierte kardiovaskuläre Erkrankungen und nicht- medikamentöse Therapieverfahren. Apothekenmagazin 2003; 21: 8-15.
19. Esch T, Stefano GB, Fricchione GL. The therapeutic use of the relaxation response in stress-related diseases. Med Sci Monit 2003; 9: RA23-34.
20. Patel C. Stress management & hypertension. Acta Physiol Scand Suppl 1997; 640: 155-157.
21. Castillo-Richmond A, Schneider RH, Alexander CN et al. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke 2000; 31: 568-573.
22. Blumenthal JA, Jiang W, Babyak MA et al. Stress management and exercise training in cardiac patients with myocardial ischemia. Effects on prognosis and evaluation of mechanisms. Arch Int Med 1997; 157: 2213-2223.
23. Ornish D, Scherwitz LW, Billings JH et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998; 280: 2001-2007.
24. Stuart EM, Caudill M, Lesermann J et al. Non-pharmacologic treatment of hypertension: A multiple-risk-factor approach. J Cardiovasc Nurs 1987; 1: 1-14.
25. Esch T, Michalsen A, Stefano GB. Endocannabinoide als molekulare Instrumente der Gesundheitsförderung. Med Monatsschr Pharm 2006; 29: 397-403.
26. Stefano GB, Esch T. Integrative medical therapy: Examination of meditation's therapeutic and global medicinal outcomes via nitric oxide. Int J Mol Med 2005; 16: 621-630.
27. Esch T, Guarna M, Bianchi E et al. Commonalities in the central nervous system's involvement with complementary medical therapies: Limbic morphinergic processes. Med Sci Monit 2004; 10: MS6-MS17.
28. Van Dixhoorn J, Duivenvoorden HJ, Pool J et al. Psychic effects of physical training and relaxation therapy after myocardial infarction. J Psychosom Res 1990; 34: 327-337.
29. Lutgendorf S, Logan H, Kirchner HL et al. Effects of relaxation and stress on the capsaicin-induced local inflammatory response. Psychosom Med 2000; 62: 524-534.
30. Patel C, Marmot M. Can general practitioners use training in relaxation and management of stress to reduce mild hypertension? Br Med J 1988; 296: 21-24.
31. Linden W, Lenz JW, Con AH. Individualized stress management for primary hypertension: A randomized trial. Arch Intern Med 2001; 161: 1071-1080.
32. Benson H, Beary JF, Carol MP. The relaxation response. Psychiatry 1974; 37:37-46.
33. Stefano GB, Fricchione GL, Esch T. Relaxation: Molecular and physiological significance. Med Sci Monit 2006; 12: HY21-31.
34. Esch T, Stefano GB. The neurobiology of pleasure, reward processes, addiction and their health implications. Neuroendocrinol Lett 2004; 25: 235-251.
35. Esch T, Guarna M, Bianchi E et al. Meditation and limbic processes. Biofeedback 2004; 32: 22-32.
36. Ospina MB, Bond TK, Karkhaneh M et al. Meditation Practices for Health: State of the Research. Evidence Report/Technology Assessment No. 155. AHRQ Publication. Rockville, Canada: Agency for Healthcare Research and Quality; 2007.
37. Hoffman JW, Benson H, Arns PA et al. Reduced sympathetic nervous system responsivity associated with the relaxation response. Science 1982; 215: 190-192.
38. Stefano GB, Fricchione GL, Slingsby BT et al. The placebo effect and relaxation response: Neural processes and their coupling to constitutive nitric oxide. Brain Res Rev 2001; 35: 1-19.
39. Dusek JA, Chang BH, Zaki J et al. Association between oxygen consumption and nitric oxide production during the relaxation response. Med Sci Monit 2006; 12: CR1-10.
40. Mantione KJ, Esch T, Stefano GB. Detection of nitric oxide in exhaled human breath: Exercise and resting determinations. Med Sci Monit 2007; 13: MT1-5.
41. Mantione KJ, Cadet P, Zhu W et al. Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: Autocrine/paracrine feedback inhibition. Addict Biol 2008 (im Druck).